141 related articles for article (PubMed ID: 33095915)
1. Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression.
Matsuo H; Wakita T; Hiramatsu H; Ohmori K; Kodama K; Nakatani K; Kamikubo Y; Iwamoto S; Kondo T; Takaori-Kondo A; Takita J; Tomizawa D; Taga T; Adachi S
Br J Haematol; 2021 Jan; 192(1):e7-e11. PubMed ID: 33095915
[No Abstract] [Full Text] [Related]
2. Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome.
Zipursky A; Thorner P; De Harven E; Christensen H; Doyle J
Leuk Res; 1994 Mar; 18(3):163-71. PubMed ID: 8139285
[TBL] [Abstract][Full Text] [Related]
3. [Megakaryoblastic leukemia and transient abnormal myelopoiesis with Down's syndrome].
Suda J; Eguchi M
Rinsho Ketsueki; 1988 Aug; 29(8):1200-6. PubMed ID: 2974493
[No Abstract] [Full Text] [Related]
4. Acute megakaryoblastic leukaemia with erythrophagocytosis.
Lobo-Olmedo A; Roldán Galiacho V; Arzuaga-Méndez J; Ancín I; García-Ruiz JC
Br J Haematol; 2021 Aug; 194(4):658. PubMed ID: 33934353
[No Abstract] [Full Text] [Related]
5. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome.
Zipursky A; Christensen H; De Harven E
Leuk Lymphoma; 1995 Jul; 18(3-4):341-7. PubMed ID: 8535203
[TBL] [Abstract][Full Text] [Related]
6. Dicentric chromosome in the bone marrow of a child with megakaryoblastic leukaemia and Down's syndrome.
Wilkie AO; Kitchen C; Oakhill A; Howell RT; Berry PJ
J Clin Pathol; 1988 Apr; 41(4):378-80. PubMed ID: 2966817
[TBL] [Abstract][Full Text] [Related]
7. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
Holt SE; Brown EJ; Zipursky A
J Pediatr Hematol Oncol; 2002 Jan; 24(1):14-7. PubMed ID: 11902731
[TBL] [Abstract][Full Text] [Related]
8. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome.
Sunami S; Fuse A; Simizu B; Eguchi M; Hayashi Y; Sugita K; Nakazawa S; Okimoto Y; Sato T; Nakajima H
Blood; 1987 Aug; 70(2):368-71. PubMed ID: 2955817
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
[TBL] [Abstract][Full Text] [Related]
10. Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.
Toft-Petersen M; Nederby L; Kjeldsen E; Kerndrup GB; Brown GD; Hokland P; Stidsholt Roug A
Br J Haematol; 2016 Nov; 175(3):393-401. PubMed ID: 27612176
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients.
Eguchi M; Ozawa T; Sakakibara H; Sugita K; Iwama Y; Furukawa T
Cancer; 1992 Jul; 70(2):451-8. PubMed ID: 1319816
[TBL] [Abstract][Full Text] [Related]
12. [Congenital acute megakaryoblastic leukemia associated with trisomy 21].
Gomis F; Pérez Sirvent ML; Borrego D; Sempere A
Sangre (Barc); 1990 Dec; 35(6):485-6. PubMed ID: 2150895
[No Abstract] [Full Text] [Related]
13. Down syndrome-like acute megakaryoblastic leukemia in a patient with Cornelia de Lange syndrome.
Vial Y; Lachenaud J; Verloes A; Besnard M; Fenneteau O; Lainey E; Marceau-Renaut A; Preudhomme C; Baruchel A; Cavé H; Drunat S
Haematologica; 2018 Jun; 103(6):e274-e276. PubMed ID: 29217785
[No Abstract] [Full Text] [Related]
14. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome.
Eguchi M; Sakaibara H; Suda J; Ozawa T; Hayashi Y; Sato T; Kojima S; Furukawa T
Br J Haematol; 1989 Nov; 73(3):315-22. PubMed ID: 2532535
[TBL] [Abstract][Full Text] [Related]
15. Use of the International System for Human Cytogenetic Nomenclature (ISCN).
Gonzalez Garcia JR; Meza-Espinoza JP
Blood; 2006 Dec; 108(12):3952-3; author reply 3953. PubMed ID: 17114573
[No Abstract] [Full Text] [Related]
16. A case of pentasomy 21 with two isochromosome 21s in acute megakaryoblastic leukemia associated with Down syndrome.
Park Y; Lim J; Ko YH; Kim J; Kwon GC; Koo SH
Ann Lab Med; 2015 May; 35(3):373-5. PubMed ID: 25932450
[No Abstract] [Full Text] [Related]
17. Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.
Taub JW; Matherly LH; Stout ML; Buck SA; Gurney JG; Ravindranath Y
Blood; 1996 Apr; 87(8):3395-403. PubMed ID: 8605357
[TBL] [Abstract][Full Text] [Related]
18. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
[TBL] [Abstract][Full Text] [Related]
19. Acute megakaryoblastic leukemia in Down syndrome: orbital infiltration.
Olson JL; May MJ; Stork L; Kadan N; Bateman JB
Am J Ophthalmol; 2000 Jul; 130(1):128-30. PubMed ID: 11004278
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia.
Sato T; Fuse A; Eguchi M; Hayashi Y; Ryo R; Adachi M; Kishimoto Y; Teramura M; Mizoguchi H; Shima Y
Br J Haematol; 1989 Jun; 72(2):184-90. PubMed ID: 2527057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
